Eli Lilly Trial Finds Alzheimer’s Drug Can Slow Progress of Disease
Donanemab is not a cure and comes with significant side effects, but patients had longer periods of independent living while on the drug.
Posted inDrugs (Pharmaceuticals) Elderly Food and Drug Administration Guillain-Barre Syndrome Respiratory Diseases Sanofi SA Vaccination and Immunization
RSV Vaccine Approved for Older Adults
The shots would be the first vaccines available against a respiratory virus that kills thousands and leads to many more hospitalizations each year.
Posted inDrugs (Pharmaceuticals) National Academies of Sciences, Engineering and Medicine Opioids and Opiates OxyContin (Drug) Pain-Relieving Drugs Philanthropy Purdue Pharma Sackler Family Science and Technology United States United States Politics and Government
National Academies Members Demand Answers About Sacklers’ Donations
The Academies accepted millions of dollars from members of the Sackler family — including some who led Purdue Pharma, makers of OxyContin — even while advising federal officials on opioid policy.
F.D.A. Approves Drug for Rare Form of A.L.S.
The drug, which will be sold as Qalsody by the pharmaceutical company Biogen, targets a genetic cause of a devastating neurological illness.